个人中心 - 老虎社区

Toh_Chris

IP属地：未知

帖子 · 66帖子 · 66
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- Toh_ChrisToh_Chris
  ·2021-10-15
  $LM Funding America(LMFA)$lucky
  2,568 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-05
  Willingness to move towards the future
  非常抱歉，此主贴已删除
  2,875 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-04
  Wonder why? Increase by $75.30!! Was it a mistake 😅😆
  4,581 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Something to consider
  5,885 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Another turn.
  Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>由于默克公司前景光明的口服 Covid 药丸，股市在 10 月初反弹</blockquote>
  WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re
  Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>由于默克公司前景光明的口服 Covid 药丸，股市在 10 月初反弹</blockquote>
  4,532 1
  6
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-10-01
  Great breakthrough!
  非常抱歉，此主贴已删除
  2,468 评论
  6
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-30
  Watchful
  非常抱歉，此主贴已删除
  4,008 评论
  5
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-29
  $Red Cat Holdings Inc.(RCAT)$Why?
  2,671 评论
  1
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-29
  $Red Cat Holdings Inc.(RCAT)$Oh! I thought it is going up😬
  2,884 评论
  点赞
  分享
  举报
- Toh_ChrisToh_Chris
  ·2021-09-28
  Great!
  Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升 45%</blockquote>
  Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou
  Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升 45%</blockquote>
  4,322 评论
  5
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4092275556517550","uuid":"4092275556517550","gmtCreate":1629173646298,"gmtModify":1630030138393,"name":"Toh_Chris","pinyin":"tohchristohchris","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":9,"headSize":27,"tweetSize":66,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.08","exceedPercentage":"93.92%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.21","exceedPercentage":"80.09%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":824691132,"gmtCreate":1634306747154,"gmtModify":1634306747383,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/LMFA\">$LM Funding America(LMFA)$</a>lucky","listText":"<a href=\"https://laohu8.com/S/LMFA\">$LM Funding America(LMFA)$</a>lucky","text":"$LM Funding America(LMFA)$lucky","images":[{"img":"https://static.tigerbbs.com/f9d7dba60cb9fda231b6250e2bcb5d74","width":"750","height":"1174"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824691132","isVote":1,"tweetType":1,"viewCount":2568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":820737466,"gmtCreate":1633431370407,"gmtModify":1633432127496,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"Willingness to move towards the future&nbsp;","listText":"Willingness to move towards the future&nbsp;","text":"Willingness to move towards the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820737466","repostId":"1133411996","repostType":4,"isVote":1,"tweetType":1,"viewCount":2875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820945712,"gmtCreate":1633346918981,"gmtModify":1633346919199,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","listText":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","text":"Wonder why? Increase by $75.30!! Was it a mistake 😅😆","images":[{"img":"https://static.tigerbbs.com/05cec00fa9d1c9f162e3e79bdb74b7d7","width":"750","height":"2201"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820945712","isVote":1,"tweetType":1,"viewCount":4581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864660319,"gmtCreate":1633097994269,"gmtModify":1633130254290,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"Something to consider&nbsp;","listText":"Something to consider&nbsp;","text":"Something to consider","images":[{"img":"https://static.tigerbbs.com/16fe2c6f0983c816203201c9e2466e34","width":"750","height":"2201"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864660319","isVote":1,"tweetType":1,"viewCount":5885,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":864680840,"gmtCreate":1633097465080,"gmtModify":1633097465278,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"Another turn.","listText":"Another turn.","text":"Another turn.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/864680840","repostId":"1145898013","repostType":4,"repost":{"id":"1145898013","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633095114,"share":"https://www.laohunote.com/m/news/1145898013?lang=zh_CN&edition=full","pubTime":"2021-10-01 21:31","market":"us","language":"en","title":"Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>由于默克公司前景光明的口服 Covid 药丸，股市在 10 月初反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1145898013","media":"Tiger Newspress","summary":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re","content":"<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p><p><blockquote>华盛顿（路透社）-美国。8 月份消费者支出增幅超出预期，但对 7 月份数据的下调保持了对第三季度经济增长放缓的预期，因为 COVID-19 感染的死灰复燃抑制了服务需求。</blockquote></p><p> Dow added 260 points, or 0.8%. The S&amp;P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p><p><blockquote>道琼斯指数上涨 260 点，涨幅 0.8%。标普500和纳斯达克综合指数分别上涨0.5%和0.2%。道指成员默克公司的股票<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a>该制药商和 Ridgeback Biotherapeutics 表示，他们针对 COVID-19 的口服抗病毒治疗可将轻度或中度病例患者的住院或死亡风险降低 50%，股价上涨 8%。两家公司计划寻求治疗的紧急授权。美国商务部周五表示，占美国经济活动三分之二以上的消费者支出8月份反弹0.8%，对全球半导体短缺导致的汽车销量下降不屑一顾，半导体短缺正在削弱汽车产量。</blockquote></p><p> The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p><p><blockquote>默克公司的新药似乎提振了旅游股。皇家加勒比和拉斯维加斯金沙的股价在盘前交易中上涨超过 1%。在摩根大通上调西南航空公司股票评级并表示该集团的大部分股票值得买入后，西南航空公司领涨航空股。</blockquote></p><p> The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p><p><blockquote>10年期国债收益率早盘回落至1.50%以下。随着收益率下降，科技含量高的纳斯达克期货上涨。</blockquote></p><p> The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&amp;P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p><p><blockquote>由于通胀担忧、增长放缓和利率上升让投资者提心吊胆，市场刚刚结束了动荡的九月。标普500本月收盘下跌 4.8%，打破了七个月的连胜纪录。道琼斯指数和纳斯达克综合指数分别下跌 4.3% 和 5.3%，遭遇今年最糟糕的几个月。</blockquote></p><p> “A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p><p><blockquote>“高盛（Goldman Sachs）董事总经理赫西（Chris Hussey）在一份报告中说：”在我们进入秋季和2021年第四季度之际，经济增长放缓、货币政策不太宽松、中国逆风、财政刺激措施逐渐消退以及供应链瓶颈挥之不去，这些因素共同打压了投资者的情绪。</blockquote></p><p> Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p><p><blockquote>第二季度消费者支出年化率强劲增长12.0%，占经济6.7%增长率的很大一部分，这使得国内生产总值水平超过了2019年第四季度的峰值。第三季度的增长预期低于 5.0%。</blockquote></p><p> \"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p><p><blockquote>摩根大通基金驻纽约首席全球策略师大卫·凯利表示：“未来几个月，消费者势头应该会有所改善，推动经济更接近大流行后的全面复苏，并保持通胀强劲。”</blockquote></p><p> Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p><p><blockquote>8月份通胀保持上升趋势。个人消费支出 (PCE) 价格指数（不包括波动较大的食品和能源成分）继 7 月份增长相同幅度后，上涨 0.3%。</blockquote></p><p> In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p><p><blockquote>在截至8月份的12个月中，所谓的核心PCE价格指数上涨了3.6%，与7月份的涨幅持平。</blockquote></p><p> The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p><p><blockquote>核心 PCE 价格指数是美联储实现其灵活 2% 目标的首选通胀指标。美联储上周将今年核心个人消费支出通胀预测从6月份的3.0%上调至3.7%。</blockquote></p><p> The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p><p><blockquote>美国央行表示，最早可能在 11 月开始减少每月债券购买量，并暗示加息速度可能会比预期更快。</blockquote></p><p> Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周四对立法者表示，他预计未来几个月高通胀将有所缓解。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>由于默克公司前景光明的口服 Covid 药丸，股市在 10 月初反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rebound to start October on Merck’s promising oral Covid pill<blockquote>由于默克公司前景光明的口服 Covid 药丸，股市在 10 月初反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-01 21:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p><p><blockquote>华盛顿（路透社）-美国。8 月份消费者支出增幅超出预期，但对 7 月份数据的下调保持了对第三季度经济增长放缓的预期，因为 COVID-19 感染的死灰复燃抑制了服务需求。</blockquote></p><p> Dow added 260 points, or 0.8%. The S&amp;P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p><p><blockquote>道琼斯指数上涨 260 点，涨幅 0.8%。标普500和纳斯达克综合指数分别上涨0.5%和0.2%。道指成员默克公司的股票<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a>该制药商和 Ridgeback Biotherapeutics 表示，他们针对 COVID-19 的口服抗病毒治疗可将轻度或中度病例患者的住院或死亡风险降低 50%，股价上涨 8%。两家公司计划寻求治疗的紧急授权。美国商务部周五表示，占美国经济活动三分之二以上的消费者支出8月份反弹0.8%，对全球半导体短缺导致的汽车销量下降不屑一顾，半导体短缺正在削弱汽车产量。</blockquote></p><p> The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p><p><blockquote>默克公司的新药似乎提振了旅游股。皇家加勒比和拉斯维加斯金沙的股价在盘前交易中上涨超过 1%。在摩根大通上调西南航空公司股票评级并表示该集团的大部分股票值得买入后，西南航空公司领涨航空股。</blockquote></p><p> The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p><p><blockquote>10年期国债收益率早盘回落至1.50%以下。随着收益率下降，科技含量高的纳斯达克期货上涨。</blockquote></p><p> The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&amp;P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p><p><blockquote>由于通胀担忧、增长放缓和利率上升让投资者提心吊胆，市场刚刚结束了动荡的九月。标普500本月收盘下跌 4.8%，打破了七个月的连胜纪录。道琼斯指数和纳斯达克综合指数分别下跌 4.3% 和 5.3%，遭遇今年最糟糕的几个月。</blockquote></p><p> “A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p><p><blockquote>“高盛（Goldman Sachs）董事总经理赫西（Chris Hussey）在一份报告中说：”在我们进入秋季和2021年第四季度之际，经济增长放缓、货币政策不太宽松、中国逆风、财政刺激措施逐渐消退以及供应链瓶颈挥之不去，这些因素共同打压了投资者的情绪。</blockquote></p><p> Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p><p><blockquote>第二季度消费者支出年化率强劲增长12.0%，占经济6.7%增长率的很大一部分，这使得国内生产总值水平超过了2019年第四季度的峰值。第三季度的增长预期低于 5.0%。</blockquote></p><p> \"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p><p><blockquote>摩根大通基金驻纽约首席全球策略师大卫·凯利表示：“未来几个月，消费者势头应该会有所改善，推动经济更接近大流行后的全面复苏，并保持通胀强劲。”</blockquote></p><p> Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p><p><blockquote>8月份通胀保持上升趋势。个人消费支出 (PCE) 价格指数（不包括波动较大的食品和能源成分）继 7 月份增长相同幅度后，上涨 0.3%。</blockquote></p><p> In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p><p><blockquote>在截至8月份的12个月中，所谓的核心PCE价格指数上涨了3.6%，与7月份的涨幅持平。</blockquote></p><p> The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p><p><blockquote>核心 PCE 价格指数是美联储实现其灵活 2% 目标的首选通胀指标。美联储上周将今年核心个人消费支出通胀预测从6月份的3.0%上调至3.7%。</blockquote></p><p> The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p><p><blockquote>美国央行表示，最早可能在 11 月开始减少每月债券购买量，并暗示加息速度可能会比预期更快。</blockquote></p><p> Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周四对立法者表示，他预计未来几个月高通胀将有所缓解。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145898013","content_text":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.\nDow added 260 points, or 0.8%. The S&P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.Shares of Dow member Merck$(MRK)$ jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.\nThe new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.\nThe 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.\nThe market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.\n“A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.\nConsumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.\n\"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.\nInflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.\nIn the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.\nThe core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.\nThe U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.\nFed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":4532,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864616200,"gmtCreate":1633097236095,"gmtModify":1633097318428,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"Great breakthrough!","listText":"Great breakthrough!","text":"Great breakthrough!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864616200","repostId":"2172968435","repostType":4,"isVote":1,"tweetType":1,"viewCount":2468,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865661848,"gmtCreate":1632976715427,"gmtModify":1632976715641,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"Watchful&nbsp;","listText":"Watchful&nbsp;","text":"Watchful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865661848","repostId":"1104172212","repostType":4,"isVote":1,"tweetType":1,"viewCount":4008,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865042991,"gmtCreate":1632926518068,"gmtModify":1632926518309,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Why?","listText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Why?","text":"$Red Cat Holdings Inc.(RCAT)$Why?","images":[{"img":"https://static.tigerbbs.com/c099945e824070ad62eb16c117983c94","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865042991","isVote":1,"tweetType":1,"viewCount":2671,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862155173,"gmtCreate":1632847556425,"gmtModify":1632847556534,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Oh! I thought it is going up😬","listText":"<a href=\"https://laohu8.com/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a>Oh! I thought it is going up😬","text":"$Red Cat Holdings Inc.(RCAT)$Oh! I thought it is going up😬","images":[{"img":"https://static.tigerbbs.com/cdb0894fff3b3e2c3723a3f1c2f61b99","width":"750","height":"1068"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862155173","isVote":1,"tweetType":1,"viewCount":2884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":862989414,"gmtCreate":1632829085061,"gmtModify":1632829085132,"author":{"id":"4092275556517550","authorId":"4092275556517550","name":"Toh_Chris","avatar":"https://static.tigerbbs.com/59542e8b00ca7947839b37f753f1b0c2","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4092275556517550","authorIdStr":"4092275556517550"},"themes":[],"title":"","htmlText":"Great!","listText":"Great!","text":"Great!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862989414","repostId":"1126986798","repostType":4,"repost":{"id":"1126986798","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632827257,"share":"https://www.laohunote.com/m/news/1126986798?lang=zh_CN&edition=full","pubTime":"2021-09-28 19:07","market":"us","language":"en","title":"Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升 45%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1126986798","media":"Tiger Newspress","summary":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-cou","content":"<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p><p><blockquote>索诺玛制药公司股价在盘前交易中飙升 45%，此前该公司在美国亚马逊上推出了首款非处方药产品，并在欧洲亚马逊上推出了一款面向消费者的新产品。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p><p><blockquote>索诺玛制药公司（Sonoma Pharmaceuticals, Inc.）是一家全球领先的医疗保健公司，致力于开发和生产稳定的次氯酸（HOCl）产品，其应用范围广泛，包括伤口护理、眼部护理、鼻部护理、口腔护理和皮肤病，该公司今天宣布推出Regenacyn的非处方药（“OTC”）。®高级疤痕凝胶和Ocucyn®亚马逊和MucoClyns上的眼睑和睫毛清洁剂™欧洲的亚马逊网站上。这三款产品均基于索诺玛的专利 Microcyn®技术，可立即用于客户订单。</blockquote></p><p> Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p><p><blockquote>索诺玛直接向消费者提供其优质、安全和有效的次氯酸产品。多年来，索诺玛一直将其产品作为处方或办公室配药产品提供，只能从医生那里获得。OTC的推出创造了一个额外的索诺玛产品系列，直接销售给消费者，并提供了一个直接渠道，使其成熟的Microcyn®所有人都可以广泛使用的技术。</blockquote></p><p> Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p><p><blockquote>Regenacyn高级疤痕凝胶经临床证明可改善疤痕的整体外观，同时减轻疼痛、瘙痒、发红和炎症。Regenacyn高级疤痕凝胶保护和滋润伤口和疤痕部位，促进更轻、更平和不那么明显的疤痕。Regenacyn高级疤痕凝胶无毒、无刺激性和无致敏性。</blockquote></p><p> Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p><p><blockquote>Ocucyn眼睑和睫毛清洁剂专为日常使用而设计，是一种安全、温和、有效的眼睑和睫毛卫生解决方案。Ocucyn眼睑和睫毛清洁剂有助于清洁肮脏和结痂的发炎眼睑。Ocucyn眼睑和睫毛清洁剂不含类固醇，无刺激性，无细胞毒性，无致敏性，不需要特殊处理。</blockquote></p><p> MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p><p><blockquote>MucoClyns是一种面部和皮肤的个人去污解决方案。MucoClyns可安全用于粘膜、割伤、擦伤、烧伤和身体表面，在意外暴露于感染风险后立即进行清洁和治疗。MucoClyns对其指示用途具有生物相容性，并且对人类皮肤安全且无刺激性。</blockquote></p><p> <b>About Sonoma Pharmaceuticals, Inc.</b></p><p><blockquote><b>关于索诺玛制药公司。</b></blockquote></p><p> Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p><p><blockquote>Sonoma Pharmaceuticals是开发和生产稳定次氯酸（HOCl）产品的全球医疗保健领导者，用于广泛的应用，包括伤口护理、动物保健、眼部护理、鼻部护理、口腔护理、消毒剂使用和皮肤病。该公司的产品以安全有效的方式减少感染、瘙痒、疼痛、疤痕和有害的炎症反应。次氯酸（HOCl）的体外和临床研究表明，它具有令人印象深刻的止痒、抗菌、抗病毒和抗炎特性。Sonoma 的稳定 HOCl 可立即缓解瘙痒和疼痛，杀死病原体并分解生物膜，不会刺痛或刺激皮肤，并为治疗部位的细胞供氧，帮助身体进行自然愈合。该公司的产品直接销售或通过合作伙伴在全球 54 个国家销售，公司正在积极寻找新的分销合作伙伴。公司总部位于佐治亚州伍德斯托克，在拉丁美洲设有制造业务。欧洲营销和销售总部位于荷兰鲁尔蒙德。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升 45%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSonoma Pharmaceuticals shares surged 45% in premarket trading<blockquote>索诺玛制药股价在盘前交易中飙升 45%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-28 19:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Sonoma Pharmaceuticals shares surged 45% in premarket trading&nbsp;after&nbsp;launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.</p><p><blockquote>索诺玛制药公司股价在盘前交易中飙升 45%，此前该公司在美国亚马逊上推出了首款非处方药产品，并在欧洲亚马逊上推出了一款面向消费者的新产品。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1b36dd566a7aa3d834858c9e28652591\" tg-width=\"850\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Sonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid &amp; Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.</p><p><blockquote>索诺玛制药公司（Sonoma Pharmaceuticals, Inc.）是一家全球领先的医疗保健公司，致力于开发和生产稳定的次氯酸（HOCl）产品，其应用范围广泛，包括伤口护理、眼部护理、鼻部护理、口腔护理和皮肤病，该公司今天宣布推出Regenacyn的非处方药（“OTC”）。®高级疤痕凝胶和Ocucyn®亚马逊和MucoClyns上的眼睑和睫毛清洁剂™欧洲的亚马逊网站上。这三款产品均基于索诺玛的专利 Microcyn®技术，可立即用于客户订单。</blockquote></p><p> Sonoma&nbsp;offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.</p><p><blockquote>索诺玛直接向消费者提供其优质、安全和有效的次氯酸产品。多年来，索诺玛一直将其产品作为处方或办公室配药产品提供，只能从医生那里获得。OTC的推出创造了一个额外的索诺玛产品系列，直接销售给消费者，并提供了一个直接渠道，使其成熟的Microcyn®所有人都可以广泛使用的技术。</blockquote></p><p> Regenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.</p><p><blockquote>Regenacyn高级疤痕凝胶经临床证明可改善疤痕的整体外观，同时减轻疼痛、瘙痒、发红和炎症。Regenacyn高级疤痕凝胶保护和滋润伤口和疤痕部位，促进更轻、更平和不那么明显的疤痕。Regenacyn高级疤痕凝胶无毒、无刺激性和无致敏性。</blockquote></p><p> Ocucyn Eyelid &amp; Eyelash Cleanser, designed for everyday use, is a safe, gentle &amp; effective solution for good eyelid &amp; eyelash hygiene. Ocucyn Eyelid &amp; Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid &amp; Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.</p><p><blockquote>Ocucyn眼睑和睫毛清洁剂专为日常使用而设计，是一种安全、温和、有效的眼睑和睫毛卫生解决方案。Ocucyn眼睑和睫毛清洁剂有助于清洁肮脏和结痂的发炎眼睑。Ocucyn眼睑和睫毛清洁剂不含类固醇，无刺激性，无细胞毒性，无致敏性，不需要特殊处理。</blockquote></p><p> MucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.</p><p><blockquote>MucoClyns是一种面部和皮肤的个人去污解决方案。MucoClyns可安全用于粘膜、割伤、擦伤、烧伤和身体表面，在意外暴露于感染风险后立即进行清洁和治疗。MucoClyns对其指示用途具有生物相容性，并且对人类皮肤安全且无刺激性。</blockquote></p><p> <b>About Sonoma Pharmaceuticals, Inc.</b></p><p><blockquote><b>关于索诺玛制药公司。</b></blockquote></p><p> Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.</p><p><blockquote>Sonoma Pharmaceuticals是开发和生产稳定次氯酸（HOCl）产品的全球医疗保健领导者，用于广泛的应用，包括伤口护理、动物保健、眼部护理、鼻部护理、口腔护理、消毒剂使用和皮肤病。该公司的产品以安全有效的方式减少感染、瘙痒、疼痛、疤痕和有害的炎症反应。次氯酸（HOCl）的体外和临床研究表明，它具有令人印象深刻的止痒、抗菌、抗病毒和抗炎特性。Sonoma 的稳定 HOCl 可立即缓解瘙痒和疼痛，杀死病原体并分解生物膜，不会刺痛或刺激皮肤，并为治疗部位的细胞供氧，帮助身体进行自然愈合。该公司的产品直接销售或通过合作伙伴在全球 54 个国家销售，公司正在积极寻找新的分销合作伙伴。公司总部位于佐治亚州伍德斯托克，在拉丁美洲设有制造业务。欧洲营销和销售总部位于荷兰鲁尔蒙德。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOA":"Sonoma Pharmaceuticals, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126986798","content_text":"Sonoma Pharmaceuticals shares surged 45% in premarket trading after launching its first over-the-counter products in the U.S. on amazon and a new consumer-focused product on amazon in Europe.\n\nSonoma Pharmaceuticals, Inc. , a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, and dermatological conditions, today announced the over-the-counter (“OTC”) consumer launch of Regenacyn®Advanced Scar Gel and Ocucyn®Eyelid & Eyelash Cleanser on Amazon.com, and MucoClyns™ on Amazon sites in Europe. All three products are based on Sonoma’s patented Microcyn®technology and are immediately available for customer orders.\nSonoma offers its superior, safe and effective hypochlorous acid products directly to consumers. For years, Sonoma has offered its products as prescription or office dispense products available only from physicians. The OTC launch creates an additional line of Sonoma products marketed directly to consumers and provides a direct channel that makes its proven Microcyn®technology widely available for all.\nRegenacyn Advanced Scar Gel is clinically proven to improve the overall appearance of scars while reducing pain, itch, redness and inflammation. Regenacyn Advanced Scar Gel protects and moisturizes wound and scar sites to promote lighter, flatter and less prominent scarring. Regenacyn Advanced Scar Gel is non-toxic, non-irritating and non-sensitizing.\nOcucyn Eyelid & Eyelash Cleanser, designed for everyday use, is a safe, gentle & effective solution for good eyelid & eyelash hygiene. Ocucyn Eyelid & Eyelash Cleanser helps clean dirty and crusty irritated eyelids. Ocucyn Eyelid & Eyelash Cleanser is steroid free, non-irritating, non-cytotoxic, non-sensitizing and requires no special handling.\nMucoClyns is a personal decontamination solution for the face and skin. MucoClyns is safe to use on mucous membranes, cuts, abrasions, burns and body surfaces to clean and treat immediately after unexpected exposure to infection risk. MucoClyns is biocompatible for its indicated use and safe and non-irritating to human skin.\nAbout Sonoma Pharmaceuticals, Inc.\nSonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, animal health care, eye care, nasal care, oral care, disinfectant use and dermatological conditions. The company’s products reduce infections, itch, pain, scarring and harmful inflammatory responses in a safe and effective manner. In-vitro and clinical studies of hypochlorous acid (HOCl) show it to have impressive antipruritic, antimicrobial, antiviral and anti-inflammatory properties. Sonoma’s stabilized HOCl immediately relieves itch and pain, kills pathogens and breaks down biofilm, does not sting or irritate skin and oxygenates the cells in the area treated assisting the body in its natural healing process. The company’s products are sold either directly or via partners in 54 countries worldwide and the company actively seeks new distribution partners. The company’s principal office is in Woodstock, Georgia, with manufacturing operations in Latin America. European marketing and sales are headquartered in Roermond, Netherlands.","news_type":1,"symbols_score_info":{"SNOA":0.9}},"isVote":1,"tweetType":1,"viewCount":4322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}